Showing 1 - 15 results of 15 for search 'John H Alexander', query time: 0.05s
Refine Results
-
1
-
2
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights F... by Konstantinos I. Gkarmiris, Johan Lindbäck, John H. Alexander, Christopher B. Granger, Peter Kastner, Renato D. Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi
Published 2024-04-01
Article -
3
Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention by Guillaume Marquis‐Gravel, Laurie‐Anne Boivin‐Proulx, Zhen Huang, Steven L. Zelenkofske, A. Michael Lincoff, Roxana Mehran, P. Gabriel Steg, Christoph Bode, John H. Alexander, Thomas J. Povsic
Published 2023-01-01
Article -
4
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events by Sofia Attelind, Pär Hallberg, Mia Wadelius, Anna-Karin Hamberg, Agneta Siegbahn, Agneta Siegbahn, Christopher B. Granger, Renato D. Lopes, John H. Alexander, Lars Wallentin, Lars Wallentin, Niclas Eriksson
Published 2022-09-01
Article -
5
Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated Collection by Patrícia O. Guimarães, Renato D. Lopes, Susanna R. Stevens, André Zimerman, Lisa Wruck, Stefan K. James, Ghazala Haque, Roberto Rocha C. V. Giraldez, John H. Alexander, Karen P. Alexander
Published 2017-04-01
Article -
6
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial by Peter T. Hu, Renato D. Lopes, Susanna R. Stevens, Lars Wallentin, Laine Thomas, John H. Alexander, Michael Hanna, Basil S. Lewis, Freek W. A. Verheugt, Christopher B. Granger, W. Schuyler Jones
Published 2017-01-01
Article -
7
Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Fai... by Marat Fudim, Daniel M. Wojdyla, John H. Alexander, Shaun G. Goodman, Roxana Mehran, Stephan Windecker, Ronald Aronson, Dragos Vinereanu, Sigrun Halvorsen, M. Cecilia Bahit, Christopher B. Granger, Renato D. Lopes
Published 2021-12-01
Article -
8
Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation by Ziad Hijazi, Christopher B. Granger, Stefan H. Hohnloser, Johan Westerbergh, Johan Lindbäck, John H. Alexander, Matyas Keltai, Alexander Parkhomenko, José L. López-Sendón, Renato D. Lopes, Agneta Siegbahn, Lars Wallentin
Published 2020-09-01
Article -
9
Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate by Paulo Roberto L. Prates, Judson B. Williams, Rajendra H. Mehta, Susanna R. Stevens, Laine Thomas, Peter K. Smith, L. Kristin Newby, Renato A. K. Kalil, John H. Alexander, Renato D. Lopes
Article -
10
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation by Ziad Hijazi, Lars Wallentin, Johan Lindbäck, John H. Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher B. Granger, Renato D. Lopes, Tymon Pol, Salim Yusuf, Jonas Oldgren, Agneta Siegbahn
Published 2020-12-01
Article -
11
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial by John H Alexander, Christopher B Granger, Sigrun Halvorsen, Stephan Windecker, Dragos Vinereanu, Daniel M Wojdyla, Roxana Mehran, Shaun Goodman, Renato Lopes, Robert C. Welsh, Payam Dehghani, Ronald Aronson, Amit N Vora, Alexander Parkhomenko
Published 2022-02-01
Article -
12
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time by Ziad Hijazi, Bertil Lindahl, Jonas Oldgren, Ulrika Andersson, Johan Lindbäck, Christopher B. Granger, John H. Alexander, Bernard J. Gersh, Michael Hanna, Veli‐Pekka Harjola, Elaine M. Hylek, Renato D. Lopes, Agneta Siegbahn, Lars Wallentin
Published 2017-11-01
Article -
13
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placeb... by Julio Rosenstock, Vlado Perkovic, John H. Alexander, Mark E. Cooper, Nikolaus Marx, Michael J. Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, David Baanstra, Egon Pfarr, Michaela Mattheus, Uli C. Broedl, Hans-Juergen Woerle, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, CARMELINA® investigators
Published 2018-03-01
Article -
14
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation by Frederik Dalgaard, Haolin Xu, Roland A. Matsouaka, Andrea M. Russo, Anne B. Curtis, Peter Vibe Rasmussen, Martin H. Ruwald, Gregg C. Fonarow, Angela Lowenstern, Morten L. Hansen, Jannik L. Pallisgaard, Karen P. Alexander, John H. Alexander, Renato D. Lopes, Christopher B. Granger, William R. Lewis, Jonathan P. Piccini, Sana M. Al‐Khatib
Published 2020-12-01
Article -
15
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Even... by Meena P. Rao, Sigrun Halvorsen, Daniel Wojdyla, Laine Thomas, John H. Alexander, Elaine M. Hylek, Michael Hanna, M. Cecilia Bahit, Renato D. Lopes, Raffaele De Caterina, Cetin Erol, Shinya Goto, Fernando Lanas, Basil S. Lewis, Steen Husted, Bernard J. Gersh, Lars Wallentin, Christopher B. Granger, the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Steering Committee and Investigators
Published 2015-12-01
Article